Positively screened women take active steps to reduce cancer risk
Summary of story from Reuters, July 29, 2011
Women who screen positive for gene mutations that promote breast and ovarian cancers usually opt for surgery to cut the risk of developing the disease.
Research carried out on 465 women in the US tested for mutations in the genes BRCA1 and BRCA2.
Results published in the journal Cancer found that more than 80 per cent who tested positive for the mutations ultimately opted for surgery to remove their ovaries, breasts or both.
According to lead researcher Dr. Marc D. Schwartz, of the Lombardi Comprehensive Cancer Center in Washington, D.C:
“There’s been a perception that risk-reducing surgery, especially risk-reducing mastectomy, was not something most mutation carriers would choose.”
However, almost all the women in the study did take some form of preventative action following their results.
Defects in the BRCA1 and BRCA2 genes significantly increase a woman’s chances of developing breast and ovarian cancers to a roughly 60 per cent change for breast cancer and a 15-40 per cent chance of ovarian cancer.
The average in the US give a woman a 12 per cent chance of developing breast cancer and 1.4 per cent for ovarian.
For women who test positive they are advised to have their ovaries removed by age 40, according to Schwartz.
This form of cancer is so much more difficult to detect and subsequently has a much higher death rate. Removal of the ovaries slashes the chances of developing cancer by 90 per cent.
Recommendations on preventative mastectomy are less clear. Removing just the ovaries in these cases may cut the chances of breast cancer in half as the ovaries are the body’s main source of estrogen. Further, unlike ovarian cancer, breast cancer can often be detected early with breast checks, MRI scans and mammograms.
About two per cent of US women would meet the screening criteria and individual doctors are increasingly ordering BRCA testing. However these women may not be given the appropriate genetic counseling after receiving their results.
Schwartz worries that away from the controlled setting of the medical centre where the tests were carried out “the results may be different”.
Many women get what’s called an “inconclusive” or “uninformative” result: They do not have a known BRCA mutation, but the possibility that they have some genetic abnormality cannot be ruled out.
For women with an inconclusive result, Schwartz said, genetic counseling can help them decide what to do.
If their family history of breast or ovarian cancers is very strong, it might be assumed that there is some sort of genetic risk. So they might still consider preventive surgery or possibly regular MRI screening for breast cancer.











